DMC BIOTECHNOLOGIES, INC.

Profile

Company Names

DMC BIOTECHNOLOGIES, INC.

Addresses

2477 55TH STREET, SUITE 120, BOULDER, CO 80301

2477 55TH STREET, SUITE 120, BOULDER, CO 80301

5333 EUCLID AVENUE, BOULDER, CO 80303

Phone Numbers

720-239-7239
(303) 210-2829
(720) 239-7239

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$48,147,284.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2025-12-16 
$1,414,267.00 
$2,500,000.00 
$1,085,733.00 
Equity, Debt 
7
2025-10-31 
$904,500.00 
$1,658,250.00 
$753,750.00 
Equity, Debt 
6
2025-04-08 
$4,791,203.00 
$10,000,000.00 
$5,208,797.00 
Equity, Debt 
5
2022-08-11 
$66,720.00 
$66,720.00 
$0.00 
 
4
2021-11-30 
$33,760,493.00 
$43,500,000.00 
$9,739,507.00 
Equity 
3
2021-01-14 
$22,446.00 
$22,446.00 
$0.00 
 
2
2019-06-18 
$4,649,995.00 
$12,000,000.00 
$7,350,005.00 
Equity 
1
2018-01-04 
$2,537,660.00 
$2,537,660.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSKO 
 
BOBANOVIC 
DIRECTOR
DOUG 
 
CAMERON 
DIRECTOR
ALASTAIR 
 
COOPER 
DIRECTOR
JIM 
 
FLATT 
EXECUTIVE OFFICER, DIRECTOR
CAROLYN 
 
FRITZ 
DIRECTOR
ASHLEY 
 
JENKINS 
EXECUTIVE OFFICER
K-LYNNE 
 
JOHNSON 
DIRECTOR
MATTHEW 
 
LIPSCOMB 
EXECUTIVE OFFICER, DIRECTOR
MATTHEW 
L. 
LIPSCOMB 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
D. 
LYNCH 
DIRECTOR
ROB 
 
VAN DER MEIJ 
DIRECTOR
JOSH 
 
YELEN 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2025-12-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2025-10-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2025-04-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-08-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2021-01-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-18 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#